Johnson & Johnson at Morgan Stanley Global Healthcare Conference Transcript
Thanks for joining us, everybody. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley. And this morning, I'm very pleased to be hosting Johnson & Johnson. Today from the company, we have Joaquin Duato, who is the company's Chairman and CEO; and John Reed, who is Executive Vice President of Pharma, R&D. Thank you both so much for joining us. Really appreciate the time today.
Before we get started, for important disclosures, please see the Morgan Stanley Research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
Well, maybe I thought we'd get started, Joaquin, you've been in the role as CEO now for almost a year. And so maybe you could provide us an update kind of first on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |